EFFECTS: An Expanded Access Program of Everolimus for Patients With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex

BMC Neurology - United Kingdom
doi 10.1186/s12883-016-0658-4

Related search